Atomoxetine is a norepinephrine reuptake inhibitor approved for the treatment of attention deficit hyperactivity disorder (ADHD). The brand name is Strattera. The initial therapeutic effects of atomoxetine usually take 2–4 weeks to become apparent. There has been some suggestion that atomoxetine might be a helpful adjunct in people with major depression, especially in cases where ADHD occurs comorbidly to major depression.
CAS Number: 2622-24-4
Molecular Weight: 283.43
Chemical Name: 10-(3-Dimethylaminopropyliden)thioxanthen
Appearance: Solid Power.
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: Soluble in DMSO
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥360 days if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined.
HS Tariff Code: 382200
- Metys J, Metysová J, Votava Z. Srovnání farmakologických vlastností prothixenu, promethazinu a chlorprothixenu [Comparison of the pharmacological properties of prothixene, promethazine and chlorprothixene]. Cesk Farm. 1966 Dec;15(10):526-30. Czech. PMID: 4382828.
- Jílek JO, Rajsner M, Pomykácek J, Protiva M. Synthetická ataraktika. XII. Prothixen a analogy. Nová synthesa chlorprothixenu [Synthetic ataraxics. XII. Prothixene and analogues. A new synthesis of chlorprothixene]. Cesk Farm. 1965 Aug;14(6):294-303. Czech. PMID: 5852321.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.